Advertisement

Methylation Analysis by DNA Immunoprecipitation (MeDIP)

  • Emily A. Vucic
  • Ian M. Wilson
  • Jennifer M. Campbell
  • Wan L. Lam
Protocol
Part of the Methods in Molecular Biology™ book series (MIMB, volume 556)

Abstract

Alteration in epigenetic regulation of gene expression is a common event in human cancer and developmental disease. CpG island hypermethylation and consequent gene silencing is observed for many genes involved in a diverse range of functions and pathways that become deregulated in the disease state. Comparative profiling of the methylome is therefore useful in disease gene discovery. The ability to identify epigenetic alterations on a global scale is imperative to understanding the patterns of gene silencing that parallel disease progression. Methylated DNA immunoprecipitation (MeDIP) is a technique that isolates methylated DNA fragments by immunoprecipitating with 5′-methylcytosine-specific antibodies. The enriched methylated DNA can then be analyzed in a locus-specific manner using PCR assay or in a genome-wide fashion by comparative genomic hybridization against a sample without MeDIP enrichment. This article describes the detailed protocol for MeDIP and hybridization of MeDIP DNA to a whole-genome tiling path BAC array.

Key words

Epigenetics DNA methylation hypermethylation hypomethylation CpG islands methylated DNA immunoprecipitation epigenetic methods and technologies array-based methylation analysis MeDIP aCGH 

Notes

Acknowledgments

The authors wish to thank Bradley Coe, Chad Malloff, and Spencer Watson for useful discussion and assistance with this manuscript. This work was supported by funds from the Canadian Institutes for Health Research, Canadian Breast Cancer Research Alliance, Genome Canada/British Columbia, and National Institute of Dental and Craniofacial Research (NIDCR) grant R01 DE15965.

References

  1. 1.
    Esteller M, Herman JG. (2002) Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol. 196, 1–7.PubMedCrossRefGoogle Scholar
  2. 2.
    Feinberg AP. (2007) Phenotypic plasticity and the epigenetics of human disease. Nature 447, 433–440.PubMedCrossRefGoogle Scholar
  3. 3.
    Ozanne SE, Constancia M. (2007) Mechanisms of disease: the developmental origins of disease and the role of the epigenotype. Nat Clin Pract Endocrinol Metab. 3, 539–546.PubMedCrossRefGoogle Scholar
  4. 4.
    Shames DS, Minna JD, Gazdar AF. (2007) DNA methylation in health, disease, and cancer. Curr Mol Med. 7, 85–102.PubMedCrossRefGoogle Scholar
  5. 5.
    Jones PA, Baylin SB. (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet. 3, 415–428.PubMedCrossRefGoogle Scholar
  6. 6.
    Feinberg AP, Ohlsson R, Henikoff S. (2006) The epigenetic progenitor origin of human cancer. Nat Rev Genet. 7, 21–33.PubMedCrossRefGoogle Scholar
  7. 7.
    Glasspool RM, Teodoridis JM, Brown R. (2006) Epigenetics as a mechanism driving polygenic clinical drug resistance. Br J Cancer. 94, 1087–1092.PubMedCrossRefGoogle Scholar
  8. 8.
    Chekhun VF, Lukyanova NY, Kovalchuk O, Tryndyak VP, Pogribny IP. (2007) Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinoma cells reveals novel hyper- and hypomethylated targets. Mol Cancer Ther. 6, 1089–1098.PubMedCrossRefGoogle Scholar
  9. 9.
    Shames DS, Girard L, Gao B, Sato M, Lewis CM, Shivapurkar N, Jiang A, Perou CM, Kim YH, Pollack JR, Fong KM, Lam CL, et al. (2006) A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies. PLoS Med. 3, e486.PubMedCrossRefGoogle Scholar
  10. 10.
    Gryn J, Zeigler ZR, Shadduck RK, Lister J, Raymond JM, Sbeitan I, Srodes C, Meisner D, Evans C. (2002) Treatment of myelodysplastic syndromes with 5-azacytidine. Leuk Res. 26, 893–897.PubMedCrossRefGoogle Scholar
  11. 11.
    Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, Lam WL, Schubeler D. (2005) Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet. 37, 853–862.PubMedCrossRefGoogle Scholar
  12. 12.
    Wilson IM, Davies JJ, Weber M, Brown CJ, Alvarez CE, MacAulay C, Schubeler D, Lam WL. (2006) Epigenomics: mapping the methylome. Cell Cycle 5, 155–158.PubMedCrossRefGoogle Scholar
  13. 13.
    Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL, Paul CL. (1992) A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A 89, 1827–1831.PubMedCrossRefGoogle Scholar
  14. 14.
    Gonzalgo ML, Liang G, Spruck CH, 3rd, Zingg JM, Rideout WM, 3rd, Jones PA. (1997) Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Cancer Res. 57, 594–599.PubMedGoogle Scholar
  15. 15.
    Huang TH, Laux DE, Hamlin BC, Tran P, Tran H, Lubahn DB. (1997) Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique. Cancer Res. 57, 1030–1034.PubMedGoogle Scholar
  16. 16.
    Livak KJ, Schmittgen TD. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402–408.PubMedCrossRefGoogle Scholar
  17. 17.
    Coe BP, Ylstra B, Carvalho B, Meijer GA, Macaulay C, Lam WL. (2007) Resolving the resolution of array CGH. Genomics 89, 647–653.PubMedCrossRefGoogle Scholar
  18. 18.
    Khojasteh M, Lam WL, Ward RK, MacAulay C. (2005) A stepwise framework for the normalization of array CGH data. BMC Bioinformatics 6, 274.PubMedCrossRefGoogle Scholar
  19. 19.
    Branham WS, Melvin CD, Han T, Desai VG, Moland CL, Scully AT, Fuscoe JC. (2007) Elimination of laboratory ozone leads to a dramatic improvement in the reproducibility of microarray gene expression measurements. BMC Biotechnol. 7, 8.PubMedCrossRefGoogle Scholar
  20. 20.
    Chi B, DeLeeuw RJ, Coe BP, MacAulay C, Lam WL. (2004) SeeGH – a software tool for visualization of whole genome array comparative genomic hybridization data. BMC Bioinformatics. 5, 13.PubMedCrossRefGoogle Scholar
  21. 21.
    Chari R, Lockwood WW, Coe BP, Chu A, Macey D, Thomson A, Davies JJ, MacAulay C, Lam WL. (2006) SIGMA: a system for integrative genomic microarray analysis of cancer genomes. BMC Genomics 7, 324.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press, a part of Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Emily A. Vucic
    • 1
  • Ian M. Wilson
    • 1
  • Jennifer M. Campbell
    • 1
  • Wan L. Lam
    • 1
  1. 1.British Columbia Cancer Research CentreVancouverCanada

Personalised recommendations